Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Gain Therapeutics, Inc. (GANX) had Return on Investments of -74.33% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-4.53M |
|
-- |
|
-- |
|
$4.37M |
|
$-4.37M |
|
$-0.06M |
|
$-4.43M |
|
$-4.43M |
|
$-4.53M |
|
$-4.53M |
|
$-4.53M |
|
$-4.53M |
|
$-4.37M |
|
$-4.35M |
|
28.68M |
|
28.68M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$11.15M |
|
$0.10M |
|
$0.47M |
|
$11.62M |
|
$5.03M |
|
$0.31M |
|
$0.82M |
|
$5.84M |
|
$5.78M |
|
$5.78M |
|
$5.78M |
|
28.75M |
|
| Cash Flow Statement Financials | |
$-3.82M |
|
-- |
|
$2.40M |
|
$10.42M |
|
$9.10M |
|
$-1.31M |
|
$0.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.22 |
|
-- |
|
-- |
|
0.05 |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.82M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-78.38% |
|
-78.38% |
|
-38.97% |
|
|
Return on Investments |
-74.33% |
$0.20 |
|
$-0.13 |
|
$-0.13 |
|